Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Appointed director
Inv. presentation
|
|
Medite Cancer Diagnostics, Inc. (MDIT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/23/2018 |
4
| ABELES JOHN H (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Acquired 40,000 shares
@ $0
Bought 266,667 shares
@ $0.075, valued at
$20k
|
|
| 10/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2018 |
4
| Lewis William Austin IV (10% Owner) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 1,100,000 shares
@ $0.075, valued at
$82.5k
|
|
| 07/30/2018 |
4
| Von Rump Stephen L. (CEO / CFO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 133,333 shares
@ $0.075, valued at
$10k
|
|
| 07/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2018 |
4
| ABELES JOHN H (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 400,000 shares
@ $0.075, valued at
$30k
|
|
| 07/05/2018 |
4
| Lewis William Austin IV (10% Owner) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 8,000,000 shares
@ $0.075, valued at
$600k
Bought 1,333,334 shares
@ $0.075, valued at
$100k
|
|
| 05/08/2018 |
4
| FORTUNOFF GREGORY (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 1,333,334 shares
@ $0.75, valued at
$1M
Bought 100,000 convertible notes
@ $0.075, valued at
$7.5k
|
|
| 02/12/2018 |
4
| Lewis William Austin IV (Director) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 10,666,667 shares
@ $0.075, valued at
$800k
Unknown transaction of 1,333,333 shares
@ $0.075, valued at
$100k
Bought 312,579 warrants
@ $0.5, valued at
$156.3k
Granted 600,000 options
@ $0.5, valued at
$300k
|
|
| 11/16/2017 |
4
| Weisman Susan (CFO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Granted 200,000 shares
@ $0.81, valued at
$162k
|
|
| 10/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2015 |
4
| Ott Michael Egbert (President and COO) has filed a Form 4 on Medite Cancer Diagnostics, Inc.|
Txns:
| Bought 156,250 shares
@ $0
Bought 156,250 shares
@ $0 |
|
| 05/28/2013 |
4
| Carbonell Xavier (Director) has filed a Form 4 on CytoCore Inc|
Txns:
| Granted 919,234 shares
@ $0.0155, valued at
$14.2k
|
|
| 05/22/2013 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc |
| 06/28/2012 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc|
Txns:
| Bought 1,301,353 shares
@ $0.02, valued at
$26k
|
|
| 02/16/2012 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc|
Txns:
| Bought 2,187,500 shares
@ $0.015, valued at
$32.8k
|
|
| 05/05/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/05/2009 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc|
Txns:
| Bought 10,000 shares
@ $0.55, valued at
$5.5k
Bought 11,000 shares
@ $0.52, valued at
$5.7k
Bought 30,000 shares
@ $0.51, valued at
$15.3k
Bought 7,500 shares
@ $0.55, valued at
$4.1k
Bought 40,000 shares
@ $0.56, valued at
$22.4k
Bought 25,000 shares
@ $0.48, valued at
$12k
Bought 22,000 shares
@ $0.44, valued at
$9.7k
Bought 1,000 shares
@ $0.45, valued at
$450
Bought 5,000 shares
@ $0.45, valued at
$2.3k
Bought 18,000 shares
@ $0.44, valued at
$7.9k
Bought 10,000 shares
@ $0.44, valued at
$4.4k
|
|
| 12/04/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/04/2008 |
4
| MCCULLOGH ROBERT F JR (CEO and CFO) has filed a Form 4 on CytoCore Inc |
|
|